Targeting KDM2B or downstream protein complexes it recruits may exploit a vulnerability in high-risk medulloblastoma subgroups that currently lack targeted therapies, according to a study led by St. Jude Children’s Research Hospital and Hopp Children’s Cancer Center Heidelberg (KiTZ).
In a study focused on aggressive breast and pancreatic cancers, scientists have discovered how tumors surrounded by a protective “scaffold” of dense, scar-like tissue manage to thrive—despite the scaffold severely restricting the blood supply and nutrient delivery essential for growth.
The first at-home urine test built to track stress patterns over time using a biological signal instead of a wearable estimate
Composition of matter patent secures exclusive protection for Anixa’s breast cancer vaccine in Australia through 2040, expanding the Company’s growing global IP estate
IDE approval enables initiation of the pivotal Safety in Ovarian Cancer for Average-Risk Women – Analysis (“SOARA”) Clinical Validation Study following Institutional Review Board approval
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
NORCROSS, Ga., Sept. 18, 2026 /PRNewswire/ — Koning Health, a global leader in advanced breast imaging technology, today announced that the Koning Breast CT System has been successfully included in the Australian Register of Therapeutic Goods (ARTG), marking an important regulatory milestone for the company’s expansion into the Australian market.
Researchers have developed a 3D map of an ovary for the first time, enabling a deeper understanding of how and when oocytes — immature eggs — are activated. Published in the journal Nature Aging, the team believes their findings have important implications for human reproductive health, as well as opening the door to future studies.
The FDA has given the go-ahead to Ultragenyx’s rebisufligene etisparvovec—now to be marketed under the brand name Fayuvi—for the treatment of Sanfilippo syndrome type A, an ulta-rare, progressive neurological condition in children.
The rete ovarii (RO) is a small structure attached directly to the ovary that has largely faded from view since it was first described more than a century ago. Its name comes from the Latin word for “network,” referring to the interconnected tubes and channels that make up the structure, according to the National Cancer Institute.